Statera Biopharma, Inc. Current Assets
Statera Biopharma, Inc. had Current Assets of $1.21 million as of 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2022-11-14
- 2022-09-30: Assets, Current $1.21M.
- 2022-06-30: Assets, Current $1.67M.
- 2022-03-31: Assets, Current $1.44M.
- 2021-12-31: Assets, Current $4.15M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2022-09-30 | $1.21M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $1.67M 10-Q · filed 2022-10-28 | |
| 2022-03-31 | $1.44M 10-Q · filed 2022-10-21 | |
| 2021-12-31 | $4.15M 10-Q · filed 2022-11-14 | |
| 2021-09-30 | $13.33M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $13.82M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $14.69M 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $925.75K 10-K · filed 2022-10-06 | $2.31M 10-K · filed 2021-03-22 |
| 2020-12-30 | $925.75K 10-Q · filed 2021-11-15 | |
| 2020-09-30 | $3.22M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $4.07M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.83M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $2.00M 10-K · filed 2021-03-22 | |
| 2019-09-30 | $2.19M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $3.05M 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $3.73M 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $4.48M 10-K · filed 2020-04-15 | |
| 2018-09-30 | $5.64M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $7.00M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $8.31M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $9.58M 10-K · filed 2019-03-07 | |
| 2017-09-30 | $10.82M 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $12.18M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | $13.82M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $15.89M 10-K · filed 2018-03-06 | |
| 2016-09-30 | $16.95M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $17.84M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $19.67M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $20.69M 10-K · filed 2017-02-22 | |
| 2015-09-30 | $23.39M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $4.99M 10-Q · filed 2015-08-12 | |
| 2015-03-31 | $5.58M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $3.55M 10-K · filed 2016-02-23 | |
| 2014-09-30 | $9.69M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $11.97M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $14.46M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $11.16M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $15.82M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $15.45M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $22.67M 10-Q · filed 2013-05-09 | |
| 2012-12-31 | $29.41M 10-K · filed 2014-03-17 | |
| 2012-09-30 | $20.55M 10-Q · filed 2012-11-09 | |
| 2012-06-30 | $23.43M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $25.22M 10-Q · filed 2012-05-07 | |
| 2011-12-31 | $31.01M 10-K · filed 2013-03-18 | |
| 2011-09-30 | $26.67M 10-Q/A · filed 2011-11-14 | |
| 2011-06-30 | $33.06M 10-Q · filed 2011-08-09 | |
| 2010-12-31 | $17.75M 10-K · filed 2012-03-13 |